Zusammenfassung
Die kardiovaskuläre Morbidität und Mortalität in den Industrienationen ist — vor allem beim männlichen Geschlecht — wesentlich durch ischämische Erkrankungen des Myokards bestimmt [18]. Ursächlich steht die Atherosklerose der epikardialen Koronararterien an erster Stelle, die zu Stenosen und Verschlüssen der Gefäße führen kann.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Anversa P, Ricci R, Olivetti G (1987) Effects of exercise on the capillary vasculature of the rat heart. Circulation 75 (suppl I): 12–18
Davies MJ, Thomas T (1981) The pathological basis and microanatomy of occlusive thrombus formation in human coronary arteries. Phil Trans R Soc Lond B 294: 225–229
Doerr W (1972) Pathologie der CoronargeffBe. Anthropologische Aspekte. Sitzungsberichte der Heidelberger Akademie der Wissenschaften Mathematisch-naturwissenschaftliche Klasse. 2. Abhandlung. Springer, Berlin Heidelberg New York
Doerr W (1979) Unspezifische Entzündungen: Koronaritis. Deutsches Ärzteblatt 32: 2033–2038
Doerr W (1983) Pathologisch-anatomische Definition der Arteriosklerose. Theorien Zur Entstehung der Arteriosklerose. Deutsches Ärzteblatt Ärztliche Mitteilungen. Sonderdruck 20: 33–43
Gertz D, Kalan JM, Kragel AH, Roberts WC, Braunwald E (1990) Gardiac morphologic findings in patients with acute myocardial infarction treated with recombinant tissue plasminogen activator. Am J Cardiol 65: 953–961
Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ (1987) Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 316: 1371–1375
Ishii T, Newman WP, Guzman MA, Hosoda Y, Strong JP (1986) Coronary and aortic atherosclerosis in young men from Tokyo and New Orleans. Lab Invest 54: 561–565
Liu MW, Roubin GS, King SB (1989) Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia. Circulation 79: 1374–1384
Silver MD (1983) Cardiovascular pathology. Churchill Livingstone, New York Edinburgh London Melbourne
Mall G, Greber D, Gharebhaghi H, Wiest G, Mattfeldt T, Ganten U (1991) Myokardprotektion und Hypertrophie-regression bei spontan hypertensiven Ratten durch Nifedipin und Moxonidin stereologische Untersuchungen In: Ganten D, Mall G ( 1991 ) Herz-Kreislauf-Regulation, Organprotektion und Organschäden. Schattauer, Stuttgart New York, pp 91–105
Pesonen E, Norio R, Sarna S (1975) Thickenings in the coronary arteries in infancy as an indication of genetic factors in coronary heart disease. Circulation 51: 218–225
Potkin BN, Roberts WC (1988) Effects of percutaneous transluminal coronary angioplasty on atherosclerotic plaques and relation of plaque composition and arterial size to outcome. Am J Cardiol 62: 41–50
Rahlf G (1985) Morphologie der intramuralen Koronararterien bei Herzhypertrophien. In: Mall G, Otto HF ( 1985 ) Herzhypertrophie. Springer, Berlin Heidelberg New York Tokio, S 144–167
Ross R (1986) The pathogenesis of atherosclerosis an update. N Engl J Med 314: 488–500
Schettler G (1985) Gangarten der Arteriosklerose. In: Mall G, Otto HF ( 1985 ) Herzhypertrophie. Springer, Berlin Heidelberg New York Tokio: 134–143
Sims FH, Gavin JB, Vanderwee MA (1989) The intima of human coronary arteries. Am Heart J 118: 32–38
Sytkowski PA, Kannel WB, D’Agostino RB (1990) Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham heart study. N Engl J Med 322: 1635–1641
Tracy RE, Devaney K, Kissling G (1985) Characteristics of the plaque under a coronary thrombus. Virch Arch A 405: 411–427
Tracy RE, Kissling GE, Lopez CR, Gandia M (1986) Histometric components of aortic atherosclerosis which vary or remain constant among eight populations. Lab Invest 54: 314–321
Virmani R, Forman MB (1989) Nonatherosclerotic ischemic heart disease. Raven Press, New York
Arnold et al. (1985) Inotropic stimulation of reperfused myocardium: effect on myocardial function. J Am Coll Cardiol 6: 1026–1034
Ballantyne CM et al. (1987) Delayed recovery of severely „stunned“ myocardium with the support of a left ventricle device after coronary artery bypass graft sugery. J Am Coll Cardiol 10: 710–712
Bolli et al. (1985) Beta adrenergic stimulation reverses post-ischemic myocardial dysfunction. Am J Cardiol 56: 964–968
Bolli R (1990) Mechanism of myocardial „stunning“. Circulation 82: 723–738
Braunwald E, Kloner RA (1982) The stunned myocardium: prolonged postischemic left ventricular dysfunction. Circulation 66: 1146–1149
Brill DA et al. (1988) Recovery of servere ischemic ventricular dysfunction after coronary artery bypass grafting. Am J Cardiol 81: 850–851
Camici P et. al. (1986) Increased uptake of F18-deoxyglucose in postischemic moycardium of patients with exercise-induced angina. Circulation 74: 81–88
Dilsizian V et al. (1990) Enhanced detection of ischemic but viable myocardium by reinjection of thallium after stress redistribution imaging. N Eng J Med 323: 141–147
Ellis SG et al. (1983) Time course of functional and biochemical recovery of myocardium salvaged by reperfusion. J Am Coll Cardiol 1: 1047–1055
Engler R (1983) Leukozyte capillary plugging in myocardial ischemia and reperfusion in the dog. Am J Physiol 111: 98–111
Gibson RS et al. (1983) Prospective assessement of regional myocardial perfusion before and after coronary revascularization by thallium-201 szintigraphy. J Am Coll Cardiol 1: 804812
Klocke FJ et al. (1974) Average coronary blood flow per unit weight of left ventricle in patients with and without coronary artery disease. Circulation 50: 547–559
Klocke FJ et al. (1977) Myocardial blood flow determined with helium desaturation and great cardiac vein/coronary sinus sampling in patients with left anterior descending artery stenosis. Herz 2: 15–11
Klocke FJ (1983) Measurements of coronary blood flow and degree of stenosis. Current clinical implications and continuing uncertainties. J Am Coll Cardiol 1: 31–41
Kloner RA et al. (1989) Altered myocardial states. Am J Med 86 (suppl. 1A): 14–22
Krause SM et al. (1986) Alterations in sarcoplasmatic reticulum Cat+ transport in post-ischemic stunned myocardium (abstr.). Circulation 74: 11–67
Kusuoka H et al. (1987) Pathophysiology of stunned myocardium. J Clin Invest 79: 950 961
Liu P et al. (1985) The persistent defect on exercise thallium imaging and its fate after myocardial revascularization. Does it represent scar or ischemia? Am Heart J 111: 996–1002
Marban E (1991) Myocardial stunning and hibernation. Circulation 83: 681–688
Marshall RC et al. (1983) Identification and differentiation of resting myocardial ischemia and infarctions in mean with PET. Circulation 67: 766–778
Matsuzaki M et al. (1983) Sustained regional dysfunction produced by prolonged coronary stenosis. Circulation 68: 170–182
McCord JM (1985) Oxygeno-derived free radials in postischemic tissue injury. N Engl J Med 312: 159–163
Nesto RW et al. (1982) Inotropic contractile reserve: a useful predictor of increased 5 year survival and improved postoperative left ventricular function in patients with coronary artery disease and reduced ejection fraction. Am J Cardiol 50: 39–44
Nixon JV et al. (1982) Identification of transient and persistent segmental wall motion abnormalities in patients with instable angina. Circulation 65: 1497–1503
Ohtani H et al. (1990) Value of Thallium-201 reinjection after delayed SPECT imaging for predicting reversible ischemia after coronary artery bypass grafting. Am J Cardiol 66: 394–399
Patch B et al. (1988) Postischemic myocardial stunning: a clinical relevant phenomenon. Ann Intern Med 108: 626–628
Popio KA et al. (1977) Postextrasystolic potentiation as a predictor of potential myocardial viability. Am J Cardiol 39: 944–953
Preuss KC et al. (1987) Time course of recovery of stunned myocardium following variable periods of ischemia. Am Heart J 114: 696–703
Przyklenk K, Kloner RA (1986) Superoxid dismutase plus katalase improve contractile function in the canine model of stunned myocardium. Circ Res 58: 148–156
Rahimtoola SH (1985) A perspective on the three large multicenter randomized clinical trials of coronary artery bypass surgery for chronic stable angina pectoris. Circulation 72: V123 - V135
Rahimtoola SH (1989) The hibernating myocardium. Am Heart J 117: 211–221
Renkin J et al. (1991) Reversal of segmental hypokinesis by coronary angioplasty in patients with unstable angina, persistent T wave inversion, and LAD coronary artery stenosis. Additional evidence for myocardial stunning-humans. Circulation 82: 913–921
Robertson WS (1983) Exercise echocardiography: a clinical practical addition in the evaluation of coronary artery disease. J Am Coll Cardiol 2: 1085–1091
Tamaki N et al. (1989) Positron Emission tomography using fluorine-18 deoxyglucose in evaluation of coronary artery bypass grafting. Am J Caridol 64: 861–865
Tennant R, Wiggers CJ (1935) The effect of coronary occlusion on myocardial contraction. J Physiol 112: 351–361
Tillisch J et al. (1986) Reversibility of cardiac wall-motion abnormalities predicted by PET. N Engl J Med 314: 884–888
Block PC (1990) Restenosis after percutaneous transluminal coronary angioplasty anatomic and pathophysiological mechanisms. Strategies for prevention. Circulation 81 (suppl IV):IV-2-IV-4
The TIMI Study Group (1989) Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial. N Engl J Med 320: 618–27
McBride W, Lange RA, Hillis LD (1988) Restenosis after successful coronary angioplasty. Pathophysiology and prevention. N Engl J Med 318: 1734–7
ACC/AHA Task Force Report (1988) Guidelines for percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 12: 529–45
Meier B (1988) Restenosis after coronary angioplasty: review of the literature. Eur Heart J 9 (suppl C): 1–6
Laarman GJ, Planté S, de Feyter PJ (1990) PTCA of chronically occluded coronary arteries. Am Heart J 119: 1153–60
Warren RJ, Black Ai, Valentine FA, Manolas EG, Hunt D (1990) Coronary angioplasty for chronic total ooclusion reduces the need for subsequent coronary bypass surgery. Am Heart J 120: 270–4
Fanelli C, Aronoff R (1990) Restenosis following coronary angioplasty. Am Heart J 119: 357–68
Liu MW, Roubin GS, King III SB (1989) Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia. Circulation 79: 1374–87
Ellis SG, Roubin GS, King III SB, Douglas JS, Cox WR (1989) Importance of stenosis morphology in the estimation of restenosis risk after elective percutaneus transluminal coronary angioplasty. Am J Cardiol 63: 30–4
Quigley PJ, Hlatky MA, Hinohara T et al. (1989) Repeat percutaneous transluminal coronary angioplasty and predictors of recurrent restenosis. Am J Cardiol 63: 409–13
Rapold HJ, David PR, Guiteras Val P, Mata AL, Crean PA, Bourassa MG (1987) Restenosis and its determinants in first and repeat coronary angioplasty. Eur Heart J 8: 575–86
Guiteras Val P, Bourassa MG, David PR et al. (1987) Restenosis after successful percutaneous transluminal coronary angioplasty: The Montreal Heart Institute experience. Am J Cardiol 60: 50B - 55B
Black AJR, Anderson HV, Roubin GS, Powelson SW, Douglas JS, King III SB (1988) Repeat coronary angioplasty: Correlates of a second restenosis. J Am Coll Cardiol 11: 714–8
Lambert M, Bonan R, Coté G et al. (1988) Multiple coronary angioplasty: A model to discriminate systemic and procedural factors related to restenosis. J Am Coll Cardiol 12: 310–4
Teirstein PS, Hoover CA, Ligon RW et al. (1989) Repeat coronary angioplasty: Efficacy of a third angioplasty for a second restenosis. J Am Coll Cardiol 13: 291–6
Leimgruber PP, Roubin GS, Hollman J et al. (1986) Restenosis after successful coronary angioplasty in patients with single-vessel disease. Circulation 73: 710–7
Barnathan ES, Schwartz JS, Taylor L et al. (1987) Aspirin and dipyridamole in the prevention of acute coronary thrombosis complicating coronary angioplasty. Circulation 76: 125–34
Schwartz L, Bourassa MG, Lespérance J et al. (1988) Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. N Engl J Med 318: 1714–9
Thornton HA, Grüntzig AR, Holtman J, King III SB, Douglas JS (1984) Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized trial. Circulation 69: 721–7
Knudtson ML, Flintoft VA, Roth DL, Hansen JL, Duff HJ (1990) Effect of short-term prostacyclin administration on restenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 15: 691–7
Ellis SG, Roubin GS, Wilentz J, Douglas JS, King III SB (1989) Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty. Am Heart J 117: 777–82
Urban P, Buller N, Fox K, Shapiro L, Bayliss J, Rickards A (1988) Lack of effect of warfarin on the restenosis rate or on clinical outcome after balloon coronary angioplasty. Br Heart J 60: 485–8
Grigg LE, Kay TWH, Valentine PA et al. (1989) Determinants of restenosis and lack of effect or dietary supplementation with eicosapentaenoic acid on the incidence of coronary artery restenosis after angioplasty. J Am Coll Cardiol 13: 665–72
Dehmer GJ, Popma JJ, van den Berg EK et al. (1988) Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids. N Engl J Med 319: 733–40
Reis GJ, Boucher TM, Sipperly ME et al. (1989) Randomised trial of fish oil for prevention of restenosis after coronary angioplasty. Lancet 1989 11: 177–81
Milner MR, Gallino RA, Leffingwell A et al. (1989) Usefulness of fish oil supplements in preventing clinical evidence of restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 64: 29–49
Hoberg E, Schwarz F, Schömig A et al. (1990) Prevention of restenosis by verapamil. The Verapamil Angioplasty Study (VAS). Circulation 82 (suppl III): III - 428
Spears JR (1987) Percutaneous transluminal coronary angioplasty restenosis: Potential prevention with laser balloon angioplasty. Am J Cardiol 60: 61B - 64B
Simpson JB, Zimmerman JJ, Selmon MR et al. (1986) Transluminal atherectomy: initial results in 27 patients. Circulation 74 (suppl II) II - 203
Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L (1987) Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 316: 701–6
Schömig A, Brachmann J, Wilhelm C et al. (1990) Recanalization of femoropopliteal occlusions by argon and excimer laser-balloon angioplasty. Eur Heart J 11 (suppl): 82
Litvack F, Grundfest WS, Segalowitz J et al. (1990) Interventional cardiovascular therapy by laser and thermal angioplasty. Circulation 81 (suppl IV):IV-109-IV-116
Karsch KR, Haase KK, Voelker W, Baumbach A, Mauser M, Seipel L (1990) Percutaneous coronary excimer laser angioplasty in patients with stable and unstable angina pectoris. Acute results and incidence of restenosis during 6-month follow-up. Circulation 81: 1849–59
Simpson JB, Rowe MH, Selmon MR et al. (1990) Restenosis following directional coronary atherectomy in de novo lesions of native coronary arteries. Circulation 82 (suppl III) III - 313
Azariades M, Fessler CL, Floten H St, Starr A (1990) Five-year results of coronary bypass grafting for patients older than 70 years: role of internal mammary artery. Ann Thorac Surg 50: 940–945
Banner HB, Standeven JW, Reese J (1985) Twelve-year experience with internal mammary artery for coronary artery bypass. J Thorac Cardiovasc Surg 90: 668–675
Bircks W (1990) Herzchirurgie Vergangenheit, Gegenwart, Zukunft. Z Kardiol 79, suppl 4: 1–5
CASS principal investigators and their associates (1983) Coronary Artery Study (CASS); a randomized trial of coronary artery bypass surgery: survival data. Circulation 68: 939–950
Frankl WS (1990) A comparison of coronary artery bypass surgery and percutaneous transluminal coronary angioplasty in the treatment of coronary angioplasty in the treatment of coronary artery disease. Modern Concepts of Cardiovascular Disease (American Heart Association) 59: 31–42
Galotti R, Mamolo G, Casucci R, Maslowsky F, Gross C, Ornaghi D, Panisi P, Semeraro F, Respighi E (1991) Reoperation for myocardial revascularization using the internal mammary artery. J Cardiovasc Surg 32: 8–11
Groudin CM (1984) Late results of coronary artery grafting: is there a flag in the field? J Thorac Cardiovasc Surg 87: 161–166
Hall RJ (1989) Coronary artery bypass in perspective. Texas Heart Institute, Journal 16: 127–130
Ivert TK, Huttunen K, Landou C, Björk VO (1988) Angiographic studies of internal mammary artery grafts 11 years after coronary artery bypass grafting. J Thorac Cardiovasc Surg 96: 1–12
Kalmar P, Irrgang E (1990) Cardiac Surgery in the Federal Republic of Germany during 1989, a report by the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surgn 38: 198–200
Kalmar P (1991) Persönliche Mitteilung, basierend auf einer noch nicht publizierten Erfassung der Deutschen Ges. f. Thorax-, Herz-and Gefäßchirurgie. Thorac Cardiovasc Surgn
Killtip T, Passamani E, Davis K, CASS principal investigators and their associates (1985) A randomized trial of coronary bypass surgery. Eight years follow-up and survival in patients with reduced ejection fraction. Circulation 72 (suppl V): 105–109
Lytle BW, Loop FD, Cosgrove DM, Ratcliffe NB, Easley K, Taylor PC (1985) Long-term (5 to 12 years) serial studies of internal mammary artery and saphenous vein coronary bypass grafts. J Thorac Cardiovasc Surg 89: 248–258
McGrath LB, Laub GW, Graf D, Gonzales-Lavin L (1990) Hospital death on a cardiac surgical service: negative influence of changing practice patterns. Ann Thorac Surg 49: 410–412
Rich MW, Keller AJ, Schechtman KB, Marshall WG, Kouchoukos NT (1988) Morbidity and mortality of coronary bypass surgery in patients 75 years of age or older. Ann Thorac Surg 46: 638–644
Schaff V, Gersh BJ, Fisher LD, Frye RL, Mock MB, Ryan JT, Eis RB, Chaitman BR, Alderman EL, Kaiser GC (1984) Detrimental effect of perioperative myocardial infarction on late survival after coronary artery bypass. Report from the Coronary Artery Surgery Study CASS. J Thorac Cardiovasc Surg 88: 972–981
Schröder T, Hörmann E, Leitz K, Engel H-J (1990) Die sofortige Bypass-Operation verhindert den Herzinfarkt beim PTCA-Notfall. Z Kardiol 79: 669–676
Takaro T, Hultgren HN, Detre KM, Peduzzi P (1982) The Veterans Administration Cooperative Study of stable angina: Current status. Circulation 65 (suppl II): 60–67
Varnauskas E, European Coronary Surgery Study group (1988) Twelve-year follow-up of survival in the randomized European Coronary Artery Surgery Study. N Engl J Med 1988: 332–337
Vukmirovic NB, Bircks W (1990) Die Bedeutung der Arteria mammaria interna als BypassgefäB. Dt Ärztebl 87: 4105–4112
Arnim T von, Szeimies-Seebach U, Erath A, Schreiber MA, Höfling B (1989) Transient ischemic episodes a marker for future cardiac events in patients with stable angina pectoris. In: Arnim T, von, Maseri, A (eds) Predisposing conditions for acute ischemic syndromes, Steinkopff, Darmstadt; Springer, Berlin Heidelberg New York Tokyo, pp 117–125
Arnim T von (1987) Silent ischemia in patients with coronary heart disease: prevalence and prognostic implications. Eur Heart J 8 (Suppl G): 115–118
Bairey CN, Rozanski A, Maddahi J, Resser KJ, Berman DS (1989) Exercise Thallium-201 scintigraphy and prognosis in typical angina pectoris and negative exercise electrocardiograpiy. Am J Cardiol 64: 282–287
Beller GA (1987) Role of nuclear cardiology in evaluating the total ischemic burden in coronary artery disease. Am J Cardiol 59:31C–38CC
Cecchi AC, Dovellini EV, Marchi F, Pucci P, Santoro GM, Fazzini PF (1983) Silent myocardial ischemia during ambulatory electrocardiographic monitoring in patients with effort angina. J Am Coll Cardiol 1: 934–939
Chatterjee K (1989) Ischemia-Silent or manifest: Does it matter? (Editorial comment) J Am Coll Cardiol 13: 1503–1505
Chiariello, M (1985) Asymptomatic transient ST changes during ambulatory ECG monitoring in diabetic patients. Am Heart J 110: 529–534
Cohn PF (1980) Silent myocardial ischemia in patients with a defective anginal warning system. Amer J Cardiol 45: 697–702
Cohn PF (1983) Prognosis and treatment of asymptomatic coronary artery disease. J Am Coll Cardiol. 1: 959–964
Cohn PF (1989) Prognosis in exercise-induced silent) ischemia: Is there a consensus? J Am Coll Cardiol 14: 893–4
Cohn PF (1984) Time for a new approach to management of patients with both symptomatic and asymptomatic episodes of myocardial ischemia. Am J Cardiol 54: 1358–1359
Cohn PF (1985) Silent myocardial ischemia: Classification, prevalence, and prognosis. Am J Med 79:Suppl. 3A: 2–6
Cohn PF (1985) Silent myocardial ischemia as a manifestation of asymptomatic coronary artery disease: What is appropriate therapy? Am J Cardiol 56: 28D - 34D
Cohn PF (1987) Silent myocardial ischemia and infarction. Dekker, New York–Goy, KM; Imperi, GA, Lambert, CR, Pepine CJ (1987) Silent myocardial ischemia during daily activities in asymptomatic men with positive exercise test responses. Am J Cardiol 59: 45–49
Deanfield JE, Kensett M, Wilson RA, Shea M, Horlock P, Landsheere CM de, Selwyn AP (1984) Silent myocardial ischaemia due to mental stress. Lancet 2: 1001–1004
Deanfield JE, Ribeiro P, Oakley K, Krikler S, Selwyn AP (1984) Analysis of ST-Segment changes in normal subjects: Implications for ambulatory monitoring in angina pectoris. Am J Cardiol 54: 1321–1325
Deanfield JE, Selwyn AP, Chierchia S, Maseri M, Ribeiro P, Krikler S (1983) Myocardial life ischaemia during daily life in patients with stable angina: its relation to symptoms and heart rate changes. Lancet 2: 753–758
Deedwania PC, Carbajal EV (1990) Silent ischemia during daily life is an independent predictor of morality in stable angina. Circulation 81: 748–756
Deedwania PC, Carbajal EV (1990) Exercise test predictors of ambulatory silent ischemia during daily life in stable angina pectoris. Am J Cardiol 66: 1151–1156
Deedwania PC, Nelson JR (1990) Pathophysiology of silent myocardial ischemia during daily life. Hemodynamic evaluation by simultaneous electrocardiographic and blood pressure monitoring. Circulation 82: 1296–1304
Droste G, Roskamm H (1983) Experimental pain measurement in patients with asymptomatic myocardial ischemia. J Am Coll Cardiol 1: 940–945
Droste C (1984) Asymptomatische Myokardischämie, In: Roskamm H. (Hrsg) Handbuch der inneren Medizin Bd IX73: Koronarerkrankungen. S 613–642
Droste C (1987) Pathophysiologie schmerzhafter and stummer Myokardischämie. Herz 12: 369–386
Ellestadt MH, Kuan P (1984) Naloxone and symptomatic ischemia: Failure to induce angina during exercise testing. Am J Cardio 54: 982–984
Erikssen J, Enge J, Forfang K, Storstein O (1976) False-positive diagnostic tests and coronary angiographic findings in 105 presumably healthy males. Circulation 54: 371–376
Faerman I, Faccio E, Milei J (1977) Autonomic neuropathy and painless myocardial infarction in diabetic patients: histologic evidence of their relationship. Diabetes 26: 1147–1158
Fisch S (1980) On the origin of cardiac pain. Arch Intern Med 140: 754–755
Freeman LJ, Nixon PGF, Sallabank P, Reaveley D (1987) Psychological stress and silent myocardial ischemia. Am Heart J 114: 477–482
Frishman WH, Teicher M (1987) Antianginal drug therapy tor silent myocardial ischemia. Am Heart J 114
Fox K (1986) The choice of therapy in chronic ischaemic heart disease. Symposium: Cardioprotection in ischaemic heart disease: Fact or Fantasy? Basel, 18. Januar
Fox K (1987) Should we treat silent ischaemia? J Cardiovasc Pharmacol 10 (Suppl. 2): S34 - S36
Giagnoni E, Secchi MB, Wu SC, Morabito A, Oltrona I, Mancarella S, Volpin N, Fossa L, Bettazzi L, Arangio G, Sachero A, Folli G (1983) Prognostic value of exercise EKG testing in asymptomatic normotensive subjects: A prospective matched study. N Eng J Med 309: 1085–1089
Gottlieb SO, Ouyang P, Mellits ED, Gerstenblith G (1985) Silent ischemia during medical therapy predicts unfavorable outcomes in unstable angina. Circulation 72: 111–163
Gottlieb SO, Weisfeldt ML, Ouyand P, Mellits ED, Gerstenblith G (1986) Silent ischemia as a marker for early unfavorable outcomes in patients with unstable angina. N Engl J Med 314: 1214–1219
Gottlieb SO, Weisfeldt ML, Ouyand P, Mellits ED, Gerstenblith G (1987) Silent ischemia predicts infarction and death during 2 year follow-up of unstable angina. J Am Coll Cardiol 10: 756–760
Grauer K (1990) Silent myocardial ischemia: dilemma or blessing? Am Fam Physician 42 (Suppl): 13S - 16S
Grossman A (1984) Endorphins and exercise. Clin Cardiol 7: 255–260
Hausdorf K (1987) Ergometrie and stumme Ischämie Winch Med Wschr 38: 664–667
Hausmann D, Nikutta P, Daniel WG, Wenzlaff P, Lichten P (1991) Determinanten für das Auftreten von Ischämie-Episoden im Langzeit-EKG bei Patienten mit positivem Belastungs-EKG. Z Kardiol 80 (Suppl. 3 ): 24 (A62)
Hecht HS, Shaw RE, Bruce T, Myler RK (1989) Silent ischemia: Evaluation by exercise and redistribution tomographic thallium-201 myocardial imaging. J Am Coll Cardiol 14: 895–900
Hendel RG, Layden JJ, Leppo JA (1990) Prognostic value of dipyridamole thallium scintigraphy for evaluation of ischemic heart disease. J Am Coll Cardiol 15: 109–116
Hoberg E, Schwarz F, Kibler W (1987) Stumme Ischämien bei stabiler Angina pectoris. Dtsch Med Wschr 112: 1197–1200
Imperi GA, Lambert CR, Coy K, Lopez L, Pepine CJ (1987) Effects of titrated beta blockade (metoprolol) on silent myocardial ischemia in ambulatory patients with coronary artery disease. Am J Cardiol 60: 519–524
Juul-Möller S, Hedblad HO, Svensson K, Hanson BS, Isacsson SO, Janzon L, Lindell SE, Steen B, Johannsson (1989) Prognostic information carried by ST segment depressions and arrhythmias in a cohort from a general population. Circulation 80: 615
Kannei WB, Abbott RD (1984) Incidence and prognosis of unrecognized myocardial infarction: An update on the Framingham Study. N Engl J Med 311: 1144–1147
Kennedy HL, Underhill SJ, Caralis DG, Khan MA, Poblete PF (1976) Detection of non-anginal or silent ischemic ST-segment depression in patients with ischemic heart disease. Am J Cardiol 37: 147
Kowalchuk GJ, Nesto RW (1989) Silent myocardial ischemia-mechanisms and rationale for therapy. Am J Med, 86 (Suppl 1A): 9–13
Lind P, Eber B, Bitner G, Költringer P, Brandt D, Klein W, Eber O (1990) 201-Tl myocardial spect and I3-endorphin levels in patients with suspected silent ischemia. Nucl-Med 29: 153–157
Löllgen H (1987) Stille Myokardischämie and ergometrische Belastungsuntersuchung. Schwerpunktmed 10: 17–24
Mark DB, Hlatky MA, Califf RM, Morris JJ, Sisson SD, McCants CB, Lee KL, Harrel FE, Pryor DB (1989) Painless exercise ST deviation on the treadmill: Long-term prognosis. J Am Coll Cardiol 14: 885–892
Maseri A (1983) The changing face of angina pectoris: Practical implications. Lancet I: 746–749
Maseri A, Chierchia S, Davies G, Glazier J (1985) Mechanisms of ischemic cardiac pain and silent myocardial ischemia. Am J Med 79; Suppl 3A: 7–11
Muller JE, Ludmer PL, Willich SN, Tofler GH, Aylmer G, Klangos I, Stone PH (1987) Circadian variation in the frequency of sudden cardiac death. Circulation 75: 131–138
Muller JE, Stone PH, Turi ZG, Rutherford JD, Czeisler CA, Parker G, Poole K, Passamani E, Roberts R, Robertson R, Sobel BE, Willerson JT, Braunwald E (1985) Milis Study Group: Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med 21: 1315–1322
Multiple Risk Factor Intervention Trial Research Group (1985) Exercise electrocardiogram and coronary heart disease mortality in the Multiple Risk Factor Intervention Trial. Am J Cardiol 55: 16–24
Nademanee K, Intarachot V, Piontek M, Vaghaiwalla M, Mody D, Josephson M, Singh BN (1984) Relationship by myocardial ischemia detected by compact Holter analog technique to that induced by ETT. Circulation 70: 11–451
Nademanee K, Intarachot V, Piontek M, Vaghaiwalla M, Mody D, Raider M, Josephson M, Singh BN (1984) Silent myocardial ischemia on Holter: Has it clinical or prognostic significance? Circulation 70: 11–451
Nademanee K, Intarachot V, Josephson MA, Rieders D, Mody D, Vahaiwalla F, Singh, BN (1987) Prognostic significance of silent myocardial ischemia in patients with unstable angina. J Am Coll Cardiol 10: 1–9
Nesto RW, Kett KJ (1988) Silent myocardial ischemia in the diabetic patient. In: Singh, B.N. (ed.). Silent myocardial ischemia and angina. Pergamon, New York Oxford Beijing Frankfurt Sao Paulo Sydney Tokyo Toronto, pp 126–133
Ouyang P, Shapiro EP, Chjandra NC, Gottlieb SH, Chew PH, Gottlieb SO (1987) An angiographic and functional comparison of patients with silent and symptomatic treadmill ischemia early after myocardial infarction. Am J Cardiol 59: 730–734
Parodi O, Simonetti I, Michelassi C, Carpeggiani C, Biagni A, L’Abbate A, Maseri A (1986) Comparison of verapamil and propranolol therapy for angina pectoris at rest. A randomized, multiple-crossover, controlled trial in the coronary care unit. Am J Cardiol 57: 899–906
Pasternack PF, Gross EA, Baumann FG, Riles TS, Lamparello PJ, Giangola G, Lawrence KP, Mintzer R, Imparato AM (1989) Beta-blockade to decrease silent myocardial ischemia during peripheral vascular surgery. Am J Surg 158: 113–116
Pohost GM (1989) „Silent Ischemia“: What is it? Editorial Comment. J Am Coll Cardiol 14, 901–2
Previtali M, Salerno J, Tavazzi L, Ray M, Medici A, Chimienti M, Specchia B, Bobba P (1980) Treatment of angina at rest with nifedipine: a short-term controlled study. Am J Cardiol 45: 825–830
Prinzmetal M, Ekmekei N, Kennamer R, Kwoczynski JK, Shubin H, Toyoshima H (1960) Variant form of angina pectoris. Previously undelineated syndrome. JAMA 174: 1794–1800
Raby KE, Goldman L, Creager MA, Cook EF, Weiberg MC, Whitemore AD, Selwyn AP (1989) Correlations between preoperative ischemia and major cardiac events after peripheral vascular surgery. N Engl J Med 321: 1296–1300
Rozanski A, Berman DS (1987) Silent myocardial ischemia. I. Pathophysiology, frequency of occurence, and approaches toward detection. Am Heart J 114: 615–626
Rozanski A, Berman DS (1987) Silent myocardial ischemia. II Prognosis and implications for the clinical assessment of patients with coronary artery disease. Am Heart J 114: 627–638
Scheler S, Motz W, Strauer BE (1989) Transiente Myokardischämien bei Hypertonikern. Z Kardio178: 1987–203
Sharma B, Asinger R, Francis GS, Hodges M, Wyeth RP (1987) Demonstration of exercise-induced painless myocardial ischemia in survivors of out-of-hospital ventricular fibrillation. Am J Cardiol 59: 740–745
Shea MJ, Deanfield JE, Wilson R, Landsheere C de, Jones T, Selwyn AP (1985) Transient ischemia in angina pectoris: frequent silent events with everyday activities. Am J Cardiol 56: 34E - 38E
Shepard JT (1985) The heart as a sensory organ. J Am Coll Cardiol 6: 83B - 87B
Sheps DS, Heiss G (1989) Sudden death and silent myocardial ischemia. Am Heart J 117: 177–184
Sheps DS, Adams KF, Hinderliter A, Price G, Bissette J, Orlando G, Margolis B, Koch G (1987) Endorphins are related to pain perception in coronary artery disease. Am J Cardiol 59: 523–527
Silber S, Vogler A (1986) Die stumme Myokardischämie: Dimensionierung eines Problems. Intensivmed 23: 52–63
Stern S, Tzivoni D (1974) Early detection of silent ischemic heart disease by 24-hour electrocardiographic monitoring of active subjects. Br Heart J 36: 481–486
Stern S, Tzivoni D, Stern Z (1975) Diagnostic accuracy of ambulatory ECG monitoring in ischemic heart disease. Circulation 52: 1045–1049
Stone PH (1987) Calcium antagonists for Prinzmetal’s variant angina, unstable angina and silent myocardial ischemia: Therapeutic tool and probe for identification of pathophysiologic mechanisms. Am J Cardiol 59: 101B - 115B
Stone GW, Spaude S, Ligon RW, Hartzler GO (1989) Usefulness of percutaneous transluminal coronary angioplasty in alleviating silent myocardial ischemia in patients with absent or minimal painful myocardial ischemia. Am J Cardiol 64: 560–564
Theroux P, Waters DD, Halphen C, Debaisieux J-G, Mizgala HF (1979) Prognostic value of exercise testing soon alter myocardial infarction. N Engl J Med 301: 341–345
Tzivoni D, Benhorin J, Gavish A, Stern S (1985) Holter recording during treadmill testing in assessing myocardial ischemic changes. Am J Cardiol 55: 1200–1203
Tzivoni D, Stern S (1990) Editorial: Prognostic significance an therapeutic implications of silent myocardial ischaemia. Eur Heart J 11: 288–293
Wall EE van der, Cats V, Blokland KAL, Bosker JA, Arndt JW, Pauwels EKJ, Bruschke AVG (1989) The effects of diltiazem on cardiac function in silent ischemia after myocardial infarction. Am Heart J 118: 655–661
Weiner DA, Ryan TJ, McCabe CH, Ng G, Chaitman BR, Sheffield T, Tristani FE, Fisher LD (1989) The role of exercise-induced silent myocardial ischemia in patients with abnormal left ventricular function. A report from the Coronary Artery Surgery Study ( CASS) registry. Am Heart J 118: 649–654
Whitaker MP, Sheps DS (1989) Prevalence of silent myocardial ischemia in survivors of cardiac arrest. Am J Cardiol 64: 591–593
Wohlgelernter D, Jaffe CC, Gabin HS, Yeatman LA, Gleman M (1987) Silent ischemia during coronary occlusion produced by balloon inflation: relation to regional myocardial dysfunction. J Am Coll Cardiol 10: 491–498
Yasue S (1979) Circadian variation of exercise capacity in patients with Prinzmetal’s variant angina: Role of exercise-induced coronary arterial spasm. Circulation 59: 938–948
Yeung AC, Barry J, Selwyn AP (1990) Silent ischemia alter myocardial infarction. Prognosis, mechanism, and intervention. Circulation 82 (suppl I):11–143–11–148
Yurenev AP, DeQuattro V, Devereux RB (1990) Hypertensive heart disease: Relationship of silent ischemia to coronary artery disease and left ventricular hypertrophy. Am. Heart J. 120: 928–933, 1990
Kannel WB, Sortie P, McNamara PM (1979) Prognosis after myocardial infarction. The Framingham Study. Am J Cardiol 44: 31–59
Gorlin R Incidence, etiology, and prognosis of heart failure. Cardiovascular Reviews and Reports 1983 4: 765–769
Pfeffer MA, Braunwald E (1990) Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 81: 1161–1172
Taylor GJ, Humphries JO, Mellits ED, Pitt B, Schulze RA, Griffith LSC, Achuff SC (1980) Predictors of clinical course, coronary anatomy and left ventricular function after recovery from acute myocardial infarction. Circulation 62: 960–969
White HD, Norris RM, Brown MA, Brandt PWT, Whitlock RML, Wild CJ (1987) Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 76: 44–51
Parmley WW, Chatterjee K (1986) Congestive heart failure and arrhythmias: An overview. Am J Cardiol 57: 34B - 37B
Gulch RW, Jacob R (1988) Geometric and muscle physiological determinantes of cardiac stroke volume as evaluated on the basis of model calculations. Basic Res Cardiol 83: 476–485
Ertl G, Gaudron P, Eilles Chr, Schorb W, Kochsiek K (1991) Compensatory mechanisms for cardiac dysfunction in myocardial infarction. Basic Res Cardiol (im Druck )
Gaudron P, Eilles C, Ertl G, Kochsiek (1990) Early remodelling of the left ventricle in patients with myocardial infarction. Eur Heart J 11 ( Suppl. B), 139–146
Maisch B, Ertl G, Eilles C, Gerhards W, Knoblauch J, Kochsiek K (1985) Left ventricular function during VVI and DVI pacing at different rates as assessed by m-mode and two-dimensional echocardiography, gated single photon emission computerized tomography (GASPECT) and thermodilution. In: Behrenbeck DW, Sorston E, Fontaine G, Winter UJ (ed) Cardiac Pacemakers, Steinkopff, Darmstadt 158–169
Jeremy RW, Hackworthy RA, Bautovich G, Hutton BF, Harris PJ (1987). Infarct artery perfusion and changes in left ventricular volume in the month after acute myocardial infarction. J Am Coll Cardiol 9: 989–995
Hochman JS, Choo H (1987) Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage. Circulation 75: 299–306
Waris EK, Siitonen L, Himanka E (1966) Heart size and prognosis in myocardial infarction. Am Heart J 71: 187–195
Marino P, Zanolla L, Zardini P (1989) Effect of strepokinase on left ventricular modeling and function after myocardial infarction: The GISSI ( Gruppo Italiano per lo Studio della Streptochinasi nell’Infarto Miocardico) Trial. J Am Coll Cardiol 14: 1149–1158
ISIS-2 (Second International Study of Infarct Survival) Collaborative Group (1988) Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 2: 349–360
CASS Principal Investigators and Their Associates (1988) Myocardial infarction and mortality in the Coronary Artery Surgery Study (CASS) randomized trial. N Engl J Med 310: 750–758
Pfeffer MA, Lamas GA, Vaughan DE, Parisi AF, Braunwald E (1988) Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med 319: 80–86
Sharpe N, Murphy J, Smith M, Hannan S (1988) Treatment of patients with symptomless left ventricular dysfunction after mycordial infarction. Lancet 1: 255–259
Jugdutt BI, Warnica JW (1988) Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion, and complications. Circulation 78: 906–919
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Kübler, W. et al. (1991). Hauptthema: Die ischaemische Herzkrankheit. In: Miehlke, K. (eds) Verhandlungen der Deutschen Gesellschaft für Innere Medizin. Verhandlungen der Deutschen Gesellschaft für Innere Medizin, vol 97. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84710-3_3
Download citation
DOI: https://doi.org/10.1007/978-3-642-84710-3_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-55080-8
Online ISBN: 978-3-642-84710-3
eBook Packages: Springer Book Archive